Product
Supplier
Encyclopedia
Inquiry
Tirzepatide API Material buy - large image1
Tirzepatide API Material buy - image1
Tirzepatide API Material buy - image2
Tirzepatide API Material buy - image3
Tirzepatide API Material buy - image4
Tirzepatide API Material buy - image5
Tirzepatide API Material buy - image6

Tirzepatide API Material

1783 Inquiries

Unit Price:

$34-36/UNIT FOB

Get Latest Price
CAS No.:

2023788-19-2

Grade:

Industrial Grade

Content:

99%

Port:

shanghai

Brand:

orient

Packaging:

1KG, 5KG, 25KG

Price valid (until):

2026-06-08

Company Type:
Trader
Location:
China
Qualification:
Main Products:

pharmaceutical intermediates,peptides,electronic chemicals

  • Product Description

  • Seller Information

  • Inquiry History

  • Description
    Product Name: Tirzepatide
    Synonyms: Tirzepatide;GIP\GLP-1;Tirzepatide (LY3298176);Trizepatide;Gip\GLP-1 Tirzepatide Ly3298176 Peptide;Tilposide;Tirzepatide(GLP-1);terzapitide
    CAS: 2023788-19-2
    MF: C225H348N48O68
    MW: 4813
    EINECS: 200-001-8
    Product Categories: APIs;API;2023788-19-2;GLP-1
    Mol File: 2023788-19-2.mol
    Shop Tirzepatide API Material-Detailed Image 1

    Tirzepatide Chemical Properties
    storage temp.  Store at -20°C
    solubility  Soluble in DMSO
    form  Solid
    color  White to off-white
    Sequence Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{diacid-C20-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

    Safety Information
    MSDS Information


    Tirzepatide Usage And Synthesis
    Description Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce  secretion.
    History Tirzepatide is a 39-amino acid synthetic peptide developed by Eli Lilly and Company. Its design is based on the sequence of a natural glucose-dependent otropic polypeptide (GIP) and simultaneously activates the glucagon-like peptide-1 (GLP-1) receptor, hence the name "twincretin." The drug first entered clinical research in 2016, with Eli Lilly initiating a Phase I clinical trial to evaluate its safety, tolerability, pharmacokinetics, and pharmacodynamics in obese or overweight subjects with related comorbidities. Subsequently, a Phase II trial further clarified its dose-response relationship and demonstrated significant blood glucose-lowering and weight-loss effects. Phase III clinical trials, including the SURPASS and SURMOUNT series, covered comparisons with placebo and active control drugs (such as semaglutide,  , and  degludec), confirming its superior efficacy in the treatment of type 2 diabetes and obesity. In May 2022, Tirzepatide, marketed under the brand name , was approved by the U.S. FDA for the treatment of type 2 diabetes, becoming the first and only approved GIP/GLP-1 dual receptor agonist . Subsequently, the drug was approved under the brand name  for weight management. Throughout the development process, Eli Lilly remained the sole original developer of the drug, and no individual scientists specifically involved in the drug design have been disclosed in publicly available literature. The structure of Tirzepatide extends its half-life to approximately 5 days by introducing α-aminoisobutyric acid (Aib) to replace alanine at positions 2 and 13 to prevent DPP-4 degradation, and by covalently binding to a C20 eicosanedioic acid via a γGlu-(AEEA-AEEA) linker at position 20 lysine residue, enabling once-weekly dosing.

    First aid measures

    If inhaled

    Move the victim into fresh air. If breathing is difficult, give oxygen. If not breathing, give artificial respiration and consult a doctor immediately. Do not use mouth to mouth resuscitation if the victim ingested or inhaled the chemical.

    Following skin contact

    Take off contaminated clothing immediately. Wash off with soap and plenty of water. Consult a doctor.

    Following eye contact

    Rinse with pure water for at least 15 minutes. Consult a doctor.

    Following ingestion

    Rinse mouth with water. Do not induce vomiting. Never give anything by mouth to an unconscious person. Call a doctor or Poison Control Center immediately.

    Accidental release measures


    Personal precautions, protective equipment and emergency procedures

    Avoid dust formation. Avoid breathing mist, gas or vapours.Avoid contacting with skin and eye. Use personal protective equipment.Wear chemical impermeable gloves. Ensure adequate ventilation.Remove all sources of ignition. Evacuate personnel to safe areas.Keep people away from and upwind of spill/leak. Environmental precautions

    Prevent further spillage or leakage if it is safe to do so. Do not let the chemical enter drains. Discharge into the environment must be avoided. Methods and materials for containment and cleaning up

    Collect and arrange disposal. Keep the chemical in suitable and closed containers for disposal. Remove all sources of ignition. Use spark-proof tools and explosion-proof equipment. Adhered or collected material should be promptly disposed of, in accordance with appropriate laws and regulations.

    Firefighting measures


    Extinguishing media

    Use dry chemical, carbon dioxide or alcohol-resistant foam.

    Specific Hazards Arising from the Chemical

    no data available

    Advice for firefighters

    Wear self-contained breathing apparatus for firefighting if necessary.


    Shop Tirzepatide API Material-Detailed Image 2

    Shop Tirzepatide API Material-Detailed Image 3

    Shop Tirzepatide API Material-Detailed Image 4


    Shop Tirzepatide API Material-Detailed Image 5

    Shop Tirzepatide API Material-Detailed Image 6

    Shop Tirzepatide API Material-Detailed Image 7


    Shop Tirzepatide API Material-Detailed Image 8

    Shop Tirzepatide API Material-Detailed Image 9

    Shop Tirzepatide API Material-Detailed Image 10


    Shop Tirzepatide API Material-Detailed Image 11

    Q1:Do you provide sample?

    A: Yes, we can provide free sample, you only need pay the shipping cost.

    Q2: What is the lead time?

    A: For stock goods, it usually take about 5-7 days by air, 15-30 days by sea,For customized products, the delivery time needs to be confirmed based on the actual situation.

    Q3: How can I buy? What is the payment method?

    A: You can contract us through Email or you can browse our website:orientchem.cc, we have bank transfer, 

    Q4:What if there are quality issues?

    A:We attach great importance to after-sales service of our products. If there are any quality issues, please contact us within 30 days of receiving the goods and we will handle returns and exchanges for you.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Inhibitor Drugs

    Characteristics
    Appearance:

    White to off-white

  • Seller Information
    Business Type:

    Trader

    Main Products:

    pharmaceutical intermediates,peptides,electronic chemicals

    Location:

    Room 102, 1st Floor, East Office Building, No. 45 Pengwan Road, Qianwan Bonded Port Area, Qingdao Zone, China (Shandong) Pilot Free Trade Zone

    Payment Terms:

    100% TT in advance

    Average lead Time:

    10

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    51-100

    Year of Establishment:

    2024

    A reliable supplier is like insurance.

    We are mainly specilized in supply of pharmaceutical intermediates, electronic chemicals,food additives, and other fine chemical products.
    Integrity is the foundation, quality is life. We would like to work together with you to build a greener and brighter future.

    Website: orientchem.cc
    Email: scarlett@orientchem.cc
    WhatsApp: +86 17753254221

  • Inquiry History
    1783 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    Tirzepatide CAS 2023788-19-2 99% White powder

    Jun 30, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Tirzepatide 99% white powder 99% powder 2023788-19-2 HSD

    1000 G Jun 27, 2023
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    10  Aug 3, 2023
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    50  Aug 17, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    United States

    Buy Tirzepatide 5mg 10mg 15mg Great Reviews 2023788-19-2 99% powder 001 HD

    1 KG Jul 3, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.